Influence of ACE inhibition on fluid metabolism in chronic heart failure and its pathophysiologic relevance

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 1, Issue 4, 1996, Pages 279-286

  Agostoni, Piergiuseppe ^a   Marenzi, Giancarlo ^a   Guazzi, Marco ^a   Guazzi, Maurizio D ^a  

^a CNR   (Italy)

Author keywords

Fluid metabolism; Functional capacity; Lung water

Indexed keywords

EID: 2042546997     PISSN: 10742484     EISSN: 19404034     Source Type: Journal    
DOI: 10.1177/107424849600100403     Document Type: Article

References (30)

1. Packer M. Neurohumoral interactions and adaptations in congestive heart failure. Circulation 77:721, 1988.
2. Peters JP. The role of sodium in the production of edema. N Engl J Med 239:353, 1948.
3. Schrier RW. Body fluid regulation in health and disease: a unifying hypothesis. Ann Intern Med 113:155, 1990.
4. Faxon DP, Creager MA, Halperin JL, Bernard DB, Ryan TJ. Redistribution of regional blood flow following angiotensin converting enzyme inhibition. Am J Med 76:104, 1984.
5. Crozier IG, Ikram H, Nicholls MG, Jans S. Acute hemodynamic, hormonal and electrolyte effects of ramipril in severe congestive heart failure. Am J Cardiol 59:155, 1987.
6. Cleland JGF, Gillen G, Dargie HJ. The effects of furosemide and angiotensin converting enzyme inhibitors and their combination on cardiac and renal haemodynamics in heart failure. Eur Heart J 9:132, 1988.
7. Van Hecken AM, Verbesselt R, Buntinx A, Cirillo VJ, de Shepper PJ. Absence of a pharmacokinetic interaction between enalapril and furosemide. Br J Clin Pharmacol 23:84, 1987.
8. McLay JS, McMurray JJ, Bridges AB, Fraser CG, Struthers AD. Acute effects of captopril on the renal actions of furosemide in patients with chronic heart failure. Am Heart J 126:879, 1993.
9. Odemuyiwa O, Gulmartin J, Kenny D, Hall RJC. Captopril and diuretic requirements in moderate and severe chronic heart failure. Eur Heart J 10:586, 1989.
10. Richardson A, Bayliss J, Scrive AJ, Parameshwar J, Poole-Wilson PA, Sutton GC. Double-blind comparison of captopril alone against furosemide plus amiloride in mild heart failure. Lancet 2:709, 1987.
11. Grinstead WC, Francis MJ, Marks GF, Tawa CB, Zoghbi WA, Young JB. Discontinuation of chronic diuretic therapy in stable congestive heart failure secondary to coronary artery disease or to idiopathic dilated cardiomyopathy. Am J Cardiol 73:881, 1991.
12. The SOLVD Investigators. Effect of enalapril on mortality and development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction. N Engl J Med 327:685, 1992.
13. Dzau VJ, Hollenberg NK. Renal response to captopril in severe heart failure: role of furosemide in natriuresis and reversal of hyponatremia. Ann Intern Med 100:777, 1984.
14. Guazzi MD, Agostoni PG, Perego B,et al.Apparent paradox of neurohumoral axis inhibition after body fluid volume depletion in patients with chronic congestive heart failure and water retention. Br Heart J 72:534, 1993.
15. Agostoni PG, Marenzi GC, Pepi M,et al.Isolated ultrafiltration in moderate congestive heart failure. J Am Coll Cardiol 21:424, 1993.
16. Rimondini A, Cipolla CM, Della Bella P, Grazi S, Sisillo E, Susini G, Guazzi MD. Hernofiltration as a short-term treatment for refractory congestive heart failure. Am J Med 83:43, 1987.
17. Cipolla CM, Grazi S, Rimondini A, Susini G, Guazzi M, Della Bella P, Guazzi MD. Changes in circulating norepinephrine with hemofiltration in advanced congestive heart failure. Am J Cardiol 66:987, 1990.
18. Pistolesi M, Giuntini C. Assessment of extravascular lung water. Radiol Clin North Am 16:551, 1978.
19. Wasserman K, Beaver WL, Whipp BJ. Gas exchange theory and lactic acidosis (anaerobic) threshold. Circulation 81(suppl II):II14, 1990.
20. Jones NL. Clinical exercise testing. Philadelphia, WB Saunders, pp. 186-207, 1988.
21. Weber KT, Janicki JS. Cardiopulmonary exercise testing for evaluation of chronic congestive heart failure. Am J Cardiol 55:22A, 1985.
22. Marenzi G, Grazi S, Giraldi F,et al.Interrelation of humoral factors, hemodynamics and fluid and salt metabolism in congestive heart failure: effects of extncorporeal ultrafiltration. Am J Med 93:49, 1993.
23. Weber KT, Kinaserwitz GT, Janicki J, Fishman AP. Oxygen utilization and ventilation during exercise in patients with chronic cardiac failure. Circulation 65:1213, 1982.
24. Burgess JH. Pulmonary diffusing capacity in disorders of the pulmonary circulation. Circulation 49:541, 1974.
25. Siegel JL, Miller A, Brown LK, De Luca A, Teirstein AS. Pulmonary diffusing capacity in left ventricular dysfunction. Chest 98:550, 1990.
26. Pun S, Baker L, Dutka DP, Oakley CM, Hughes JMB, Cleland JGF. Reduced alveolar capillary membrane diffusing capacity in chronic heart failure: its pathophysiological relevance and relationship to exercise performance. Circulation 91:2769, 1995.
27. Kraemer MD, Kubo SH, Rector TS, Brunsvold N, Bank AJ. Pulmonary and peripheral vascular factors are important determinants of peak exercise oxygen uptake in patients with heart failure. J Am Coll Cardiol 21:641, 1993.
28. Mancini DM, Henson D, La Manca J, Donchez L, Levine S. Benefit of selective respiratory muscle training on exercise capacity in patients with chronic congestive heart failure. Circulation 91:320, 1995.
29. Meyers J, Froelicher VF. Hemodynamic determinants of exercise capacity in chronic heart failure. Ann Intern Med 115:377, 1991.
30. Pitt B, Chang P, Timmermans PBMWVM. Angiotensin II receptor antagonists and design of the evaluation of Losartan in the elderly (ELITE) trial. Cardiovasc Drug Ther 9:693, 1995.